Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
3 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Faeth Therapeutics, Inc.’s names, not what it holds today.
Patents granted
3
3 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against 2 in 2024 and none in 2023
Applications published
11
4 of them in 2025
Names they are printed under
4
its own name, a former name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Faeth Therapeutics, Inc. its own name
named as the applicant on its applications, in US
7 publishedSENSEI BIOTHERAPEUTICS, INC. a former name
named as the applicant on its applications, in US
3 publishedFaeth Therapeutics, Inc. its own name
US, as the owner printed on each patent
0 publishedSensei Biotherapeutics, Inc. a former name
US, as the owner printed on each patent
1 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Feb 11, 2025 | 12,220,402 | Formulations for personalized methods of treatment | Pharmaceuticals | Faeth Therapeutics, Inc. |
| Oct 8, 2024 | 12,109,184 | Personalized methods of treating cancer | Pharmaceuticals | Faeth Therapeutics, Inc. |
| Mar 19, 2024 | 11,932,695 | Modified antibodies and related compounds, compositions and methods of use | Pharmaceuticals | Sensei Biotherapeutics, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 4, 2025 | 2025/0367169 | FORMULATIONS FOR PERSONALIZED METHODS OF TREATMENT | Pharmaceuticals | Faeth Therapeutics, Inc. |
| May 8, 2025 | 2025/0144067 | PERSONALIZED STARVATION THERAPY FOR CANCER | Pharmaceuticals | Faeth Therapeutics, Inc. |
| Mar 13, 2025 | 2025/0082643 | COMBINATION THERAPY FOR PIK3CA-ASSOCIATED DISEASES OR DISORDERS | Pharmaceuticals | Faeth Therapeutics, Inc. |
| Jan 16, 2025 | 2025/0020651 | PERSONALIZED MODULATION THERAPY FOR CANCER | Pharmaceuticals | Faeth Therapeutics, Inc. |
| Aug 31, 2023 | 2023/0272082 | ANTI-VISTA ANTIBODIES AND USES THEREOF | Pharmaceuticals | Sensei Biotherapeutics, Inc. |
| Jun 23, 2022 | 2022/0193447 | METHODS FOR MODULATION OF AND SENSITIZATION TO SERINE AND GLYCINE LIMITATION | Pharmaceuticals | Faeth Therapeutics, Inc. |
| Apr 21, 2022 | 2022/0117943 | FORMULATIONS FOR PERSONALIZED METHODS OF TREATMENT | Pharmaceuticals | Faeth Therapeutics, Inc. · patent 12,220,402 granted from it |
| Feb 24, 2022 | 2022/0054444 | PERSONALIZED METHODS OF TREATING CANCER | Pharmaceuticals | Faeth Therapeutics, Inc. · patent 12,109,184 granted from it |
| Nov 5, 2020 | 2020/0345820 | COMBINATION THERAPIES FOR CANCER | Pharmaceuticals | SENSEI BIOTHERAPEUTICS, INC. |
| Apr 23, 2020 | 2020/0121773 | COMPOSITIONS AND METHODS FOR MANUFACTURING BACTERIOPHAGE CANCER VACCINES AND USES THEREOF | Pharmaceuticals | SENSEI BIOTHERAPEUTICS, INC. |
What it applied for, 2024 to 2025: Pharmaceuticals 4.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.